EMEA-001940-PIP01-16-M06 - paediatric investigation plan
lamivudine
dolutegravir
PIPHuman
Key facts
- Invented name
- Dovato
- Active Substance
- lamivudine
- dolutegravir
- Therapeutic area
- Infections and infestations
- Decision number
- P/0243/2024
- PIP number
- EMEA-001940-PIP01-16-M06
- Pharmaceutical form(s)
- Dispersible tablet
- Film-coated tablet
- Condition(s) / indication(s)
- Treatment of human immunodeficiency virus (HIV-1) infection
- Route(s) of administration
- Oral use
- Contact for public enquiries
ViiV Healthcare UK Limited
E-mail: eu.paediatric-plans@gsk.com
Tel: +1 4388998201- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date